scispace - formally typeset
K

Klaus Seuwen

Researcher at Novartis

Publications -  79
Citations -  5144

Klaus Seuwen is an academic researcher from Novartis. The author has contributed to research in topics: Receptor & G protein-coupled receptor. The author has an hindex of 36, co-authored 77 publications receiving 4582 citations. Previous affiliations of Klaus Seuwen include University of Zurich & Scripps Research Institute.

Papers
More filters
Journal ArticleDOI

Proton-sensing G-protein-coupled receptors

TL;DR: It is shown that ovarian cancer G-protein-coupled receptor 1 (OGR1), previously described as a receptor for sphingosylphosphorylcholine, acts as a proton-sensing receptor stimulating inositol phosphate formation, and that GPR4, a close relative of OGR1, also responds to pH changes, but elicits cyclic AMP formation.
Journal ArticleDOI

The 7 TM G-protein-coupled receptor target family.

TL;DR: How GPCR‐directed drug discovery was initially based on the careful testing of a few specifically made chemical compounds and is today pursued with modern drug discovery approaches, including combinatorial library design, structural biology, molecular informatics, and advanced screening technologies for the identification of new compounds that activate or inhibit GPCRs specifically.
Journal ArticleDOI

Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors

TL;DR: It is demonstrated that persistent signaling translates into an increased chemokinetic migration of primary human umbilical vein endothelial cells, which suggests persistent agonism as a crucial parameter in the mechanism of action of FTY720.
Journal ArticleDOI

Stem cell characteristics of human trabecular bone-derived cells

TL;DR: It is shown that HTBs readily differentiate into osteoblasts, chondrocytes, and adipocytes if subjected to the appropriate differentiating conditions, and differentiation into these three lineages is maintained in single cell clones derived by limiting dilution, following expansion over more than 20 cumulative population doublings.